Sanofi, GSK, request FDA authorization for traditional, protein-based Covid vaccine

Pharmaceutical giants Sanofi and GSK have submitted a joint-application to the FDA for authorization for a two-dose COVID-19 vaccine and booster shot.

from U.S. Home | Mail Online https://ift.tt/UdiJVgt

Post a Comment

0 Comments